טוען...
Evolving Management Strategies for Metastatic Esophageal and Gastroesophageal Junction Adenocarcinoma
Metastatic or unresectable esophageal and gastroesophageal junction adenocarcinoma represent a devastating disease with 5-year survival rate of <5%. Although cytotoxic chemotherapy with platinum-doublet-based regimens is initially effective, patients inevitably progress. Patients often decline ra...
שמור ב:
| הוצא לאור ב: | Oncol Hematol Rev |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527138/ https://ncbi.nlm.nih.gov/pubmed/31119034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17925/OHR.2018.14.2.82 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|